CompletedNot applicableNCT04169828

The Ondansetron Premedication Trial in Juvenile Idiopathic Arthritis

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of British Columbia
Principal Investigator
Jaime Guzman, MD, FRCPC
University of British Columbia
Intervention
Methotrexate(drug)
Enrollment
52 enrolled
Eligibility
4-16 years · All sexes
Timeline
20192025

Study locations (11)

Collaborators

The Arthritis Society, Canada · University of Calgary · The Hospital for Sick Children · McGill University Health Centre/Research Institute of the McGill University Health Centre · London Health Sciences Centre · University of Manitoba · Alberta Children's Hospital · McMaster University · McMaster Children's Hospital · Université de Montréal

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04169828 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis

← Back to all trials